Page last updated: 2024-10-25

ciglitazone and Liver Dysfunction

ciglitazone has been researched along with Liver Dysfunction in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research Excerpts

ExcerptRelevanceReference
"Hemorrhagic shock was induced in anesthetized young (3-5 mo old) and mature male Wistar rats (11-13 mo old) by withdrawing blood to a mean arterial blood pressure of 50 mmHg."1.36Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock. ( Chima, R; Denenberg, A; Hake, PW; O'Connor, M; Piraino, G; Zingarelli, B, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zingarelli, B1
Chima, R1
O'Connor, M1
Piraino, G1
Denenberg, A1
Hake, PW1

Other Studies

1 other study available for ciglitazone and Liver Dysfunction

ArticleYear
Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.
    American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:1

    Topics: Age Factors; Alanine Transaminase; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; C

2010